Farouq Muhammad Dayyab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Farouq Muhammad Dayyab has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
Abdulrazaq Garba Habib
Infectious Disease Unit, Department of Medicine, College of Health Sciences, Bayero University, Kano, Kano State, Nigeria
10 shared publicationsGarba Iliyasu
Infectious Disease Unit, Department of Medicine, College of Health Sciences, Bayero University, Kano, Kano State, Nigeria
8 shared publications- Garba Iliyasu
Department of Medicine, College of Health Sciences, Bayero University, Kano, Nigeria
5 shared publications - Abdulwasiu Bolaji Tiamiyu
HJF Medical Research International, Abuja, Nigeria
3 shared publications Aliyu Aminu
Department of Medical Microbiology and Parasitology, College of Health Sciences, Bayero University, Kano, Nigeria (Dr Aminu)
3 shared publicationsBashir Garba Ahmad
Department of Medicine, Muhammad Abdullahi Wase Teaching Hospital, Kano, Kano State, Nigeria
3 shared publications
Latest Publications
- Open Access
- 28 September 2023
- Published by Elsevier in Journal of Intensive Medicine
- Vol. 4 (1) , 94-100
Infectious causes of fever of unknown origin in developing countries: An international ID-IRI study
- 28 September 2023
- Published by Elsevier in Journal of Intensive Medicine
- Vol. 4 (1) , 94-100
Open AccessInfectious causes of fever of unknown origin in developing countries: An international ID-IRI study
- Open Access
- 1 September 2023
- Published by KEAI Publishing in Journal of Safety Science and Resilience
- Vol. 4 (3) , 262-264
Re-emergence of Ebola virus disease in Uganda: Should Southeast Asia countries be worried?
- 1 September 2023
- Published by KEAI Publishing in Journal of Safety Science and Resilience
- Vol. 4 (3) , 262-264
Open AccessRe-emergence of Ebola virus disease in Uganda: Should Southeast Asia countries be worried?
- Open Access
- 14 April 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (5) , e2990
Perceived changes in the mental well‐being among Nigerians due to Ramadan Intermittent Fasting during the COVID‐19 pandemic
Introduction: Muslims fast every year during the month of Ramadan from dawn until dusk. This study examined mental well‐being and correlating factors among Nigerian adults who observed Ramadan intermittent fasting (RIF).Methods: A validated generalized anxiety disorder‐2 and Patient Health Questionnaire‐2, the four‐item spiritual well‐being index, and the Islamic intrinsic religiosity questionnaire were used to collect data about mental well‐being (depression, anxiety), spirituality, and intrinsic religiosity through a web‐based survey between the May 9, 2021 (27th of Ramadan, 1442) and the June 4, 2021 (29th of Shawwal, 1442). We studied the mental well‐being of respondents over a period of 4 weeks before Ramadan (BR) and during the 4 weeks of Ramadan between the April 12, 2021 and the May 12, 2021(DR). Multinomial regression analysis was used to determine the factors associated with depression and anxiety. This research did not receive any grant or funding.Results: A total of 770 adult Nigerians who observed RIF study were included in this cross‐sectional study. When compared to mental well‐being BR, observing RIF by Nigerian adult respondents was associated with a significant improvement in their mental well‐being. A higher proportion of respondents felt less depressed DR (61.3% vs. 56.5%. < .001). Interest and pleasure in doing things improved DR than BR (p= 0.007) and respondents felt less nervous and anxious (60.7% vs. 57.1%, respectively; p <.001). Mental well‐being was independently associated with sociodemographic characteristics, physical activity, and perceived relationships.Conclusions: This study found significant improvement in mental well‐being DR compared to BR despite the ongoing COVID‐19 pandemic. The effect of RIF on mental well‐being needs further research with multicentric studies among different sets of ethnic populations.
- 14 April 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (5) , e2990
Open AccessPerceived changes in the mental well‐being among Nigerians due to Ramadan Intermittent Fasting during the COVID‐19 pandemic
Introduction: Muslims fast every year during the month of Ramadan from dawn until dusk. This study examined mental well‐being and correlating factors among Nigerian adults who observed Ramadan intermittent fasting (RIF).Methods: A validated generalized anxiety disorder‐2 and Patient Health Questionnaire‐2, the four‐item spiritual well‐being index, and the Islamic intrinsic religiosity questionnaire were used to collect data about mental well‐being (depression, anxiety), spirituality, and intrinsic religiosity through a web‐based survey between the May 9, 2021 (27th of Ramadan, 1442) and the June 4, 2021 (29th of Shawwal, 1442). We studied the mental well‐being of respondents over a period of 4 weeks before Ramadan (BR) and during the 4 weeks of Ramadan between the April 12, 2021 and the May 12, 2021(DR). Multinomial regression analysis was used to determine the factors associated with depression and anxiety. This research did not receive any grant or funding.Results: A total of 770 adult Nigerians who observed RIF study were included in this cross‐sectional study. When compared to mental well‐being BR, observing RIF by Nigerian adult respondents was associated with a significant improvement in their mental well‐being. A higher proportion of respondents felt less depressed DR (61.3% vs. 56.5%. < .001). Interest and pleasure in doing things improved DR than BR (p= 0.007) and respondents felt less nervous and anxious (60.7% vs. 57.1%, respectively; p <.001). Mental well‐being was independently associated with sociodemographic characteristics, physical activity, and perceived relationships.Conclusions: This study found significant improvement in mental well‐being DR compared to BR despite the ongoing COVID‐19 pandemic. The effect of RIF on mental well‐being needs further research with multicentric studies among different sets of ethnic populations.
- Open Access
- 6 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281455
Determinants of mortality among hospitalized patients with COVID-19 during first and second waves of the pandemic: A retrospective cohort study from an isolation center in Kano, Nigeria
Coronavirus disease 2019 (COVID-19) has emerged as an important cause of morbidity and mortality worldwide. The aim of this study is to identify the clinical predictors of mortality among patients with COVID-19 pneumonia during first and second waves in a treatment center in northwestern Nigeria. This was a retrospective cohort study of 195 patients hospitalized with COVID-19 between April 2020 to March 2021 at a designated COVID-19 isolation center in Kano State, Northwest Nigeria. Data were summarized using frequencies and percentages. Unadjusted odds ratios and 95% confidence intervals and p-values were obtained. To determine independent determinants of mortality, we performed a stepwise multivariate logistic regression model. Of 195 patients studied, 21(10.77%) patients died. Males comprised 158 (81.03%) of the study population. In the adjusted stepwise logistic regression analysis, age>64 years (OR = 9.476, 95% CI: 2.181–41.165), second wave of the pandemic (OR = 49.340, 95% CI:6.222–391.247), cardiac complications (OR = 24.984, 95% CI: 3.618–172.508), hypertension (OR = 5.831, 95% CI:1.413–24.065) and lowest systolic blood pressure while on admission greater than or equal to 90mmHg were independent predictors of mortality (OR = 0.111, 95%CI: 0.021–0.581). Strategies targeted to prioritize needed care to patients with identified factors that predict mortality might improve patient outcome.
- 6 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281455
Open AccessDeterminants of mortality among hospitalized patients with COVID-19 during first and second waves of the pandemic: A retrospective cohort study from an isolation center in Kano, Nigeria
Coronavirus disease 2019 (COVID-19) has emerged as an important cause of morbidity and mortality worldwide. The aim of this study is to identify the clinical predictors of mortality among patients with COVID-19 pneumonia during first and second waves in a treatment center in northwestern Nigeria. This was a retrospective cohort study of 195 patients hospitalized with COVID-19 between April 2020 to March 2021 at a designated COVID-19 isolation center in Kano State, Northwest Nigeria. Data were summarized using frequencies and percentages. Unadjusted odds ratios and 95% confidence intervals and p-values were obtained. To determine independent determinants of mortality, we performed a stepwise multivariate logistic regression model. Of 195 patients studied, 21(10.77%) patients died. Males comprised 158 (81.03%) of the study population. In the adjusted stepwise logistic regression analysis, age>64 years (OR = 9.476, 95% CI: 2.181–41.165), second wave of the pandemic (OR = 49.340, 95% CI:6.222–391.247), cardiac complications (OR = 24.984, 95% CI: 3.618–172.508), hypertension (OR = 5.831, 95% CI:1.413–24.065) and lowest systolic blood pressure while on admission greater than or equal to 90mmHg were independent predictors of mortality (OR = 0.111, 95%CI: 0.021–0.581). Strategies targeted to prioritize needed care to patients with identified factors that predict mortality might improve patient outcome.
- Open Access
- 1 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0278224
A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs)
Introduction: Malaria is the second leading cause of death in children after diarrheal disease, with low- and middle-income countries (LMICs) accounting for over 9 in 10 incidence and deaths. Widespread acceptance and uptake of the RTS,S vaccine, recently approved by the world health organization (WHO), is projected to significantly reduce malaria incidence and deaths. Therefore, we conducted this systematic review and meta-analysis with the aim to determine the malaria vaccine acceptance rate and the factors associated with acceptance.Methods: We searched six databases including Google Scholar, PubMed, Cochrane, African Index Medicus, The Regional Office for Africa Library, and WHO Institutional Repository for Information Sharing (IRIS) to identify studies evaluating the malaria vaccine acceptance rate. This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Studies were included if they were original articles published in the English language in peer-reviewed journals and assessed the prevalence of willingness to accept a free malaria vaccine, and not qualitative. The risk of publication bias was checked using both Beggar’s funnel plot and Egger’s test, while the I2statistic was used to assess the heterogeneity of the included studies. Study quality was determined using the Newcastle-Ottawa scale. A meta-analysis was performed using a random effects model to evaluate the pooled prevalence of malaria vaccine acceptance. The protocol for this article was registered prospectively on the International Prospective Register for Systematic Reviews (PROSPERO), with ID number CRD42022334282).Results: Our analysis included 11 studies with a total sample size of 14, 666 participants. The aggregate malaria vaccine acceptance rate was 95.3% (95% CI:93.0%–97.2%). Among the general population, the acceptance rate was 96.3% (95% CI:92.0%–99.0%) and among mothers, it was 94.4% (95% CI:90.8%–97.2%). By country, Nigeria had the highest acceptance rate (97.6%, 95% CI:96.0%-98.8%), followed by Ghana (94.6%, 95% CI:93.8%-95.3%) and Tanzania (92.5%, 95% CI:84.4%-97.8%). Sociodemographic determinants of vaccine acceptance included place of residence, tribe, age, sex, occupation, and religion. Reasons for low acceptance included safety concerns, efficacy profile, vaccine’s requirement for multiple injections, and poor level of awareness.Conclusion: Future efforts should be focused on identifying factors that may improve the actual uptake of the RTS,S vaccine in malaria-endemic communities.
- 1 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0278224
Open AccessA systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs)
Introduction: Malaria is the second leading cause of death in children after diarrheal disease, with low- and middle-income countries (LMICs) accounting for over 9 in 10 incidence and deaths. Widespread acceptance and uptake of the RTS,S vaccine, recently approved by the world health organization (WHO), is projected to significantly reduce malaria incidence and deaths. Therefore, we conducted this systematic review and meta-analysis with the aim to determine the malaria vaccine acceptance rate and the factors associated with acceptance.Methods: We searched six databases including Google Scholar, PubMed, Cochrane, African Index Medicus, The Regional Office for Africa Library, and WHO Institutional Repository for Information Sharing (IRIS) to identify studies evaluating the malaria vaccine acceptance rate. This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Studies were included if they were original articles published in the English language in peer-reviewed journals and assessed the prevalence of willingness to accept a free malaria vaccine, and not qualitative. The risk of publication bias was checked using both Beggar’s funnel plot and Egger’s test, while the I2statistic was used to assess the heterogeneity of the included studies. Study quality was determined using the Newcastle-Ottawa scale. A meta-analysis was performed using a random effects model to evaluate the pooled prevalence of malaria vaccine acceptance. The protocol for this article was registered prospectively on the International Prospective Register for Systematic Reviews (PROSPERO), with ID number CRD42022334282).Results: Our analysis included 11 studies with a total sample size of 14, 666 participants. The aggregate malaria vaccine acceptance rate was 95.3% (95% CI:93.0%–97.2%). Among the general population, the acceptance rate was 96.3% (95% CI:92.0%–99.0%) and among mothers, it was 94.4% (95% CI:90.8%–97.2%). By country, Nigeria had the highest acceptance rate (97.6%, 95% CI:96.0%-98.8%), followed by Ghana (94.6%, 95% CI:93.8%-95.3%) and Tanzania (92.5%, 95% CI:84.4%-97.8%). Sociodemographic determinants of vaccine acceptance included place of residence, tribe, age, sex, occupation, and religion. Reasons for low acceptance included safety concerns, efficacy profile, vaccine’s requirement for multiple injections, and poor level of awareness.Conclusion: Future efforts should be focused on identifying factors that may improve the actual uptake of the RTS,S vaccine in malaria-endemic communities.
- Open Access
- 5 November 2022
- Published by Elsevier in AJOG Global Reports
- Vol. 2 (4) , 100130
Monkeypox in human pregnancy: an overview
- 5 November 2022
- Published by Elsevier in AJOG Global Reports
- Vol. 2 (4) , 100130
Open AccessMonkeypox in human pregnancy: an overview
- 22 September 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 106, 106942
Poliomyelitis in the United States during COVID-19 and monkeypox outbreak: Totally vaccine preventable diseases?
- 22 September 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 106, 106942
Poliomyelitis in the United States during COVID-19 and monkeypox outbreak: Totally vaccine preventable diseases?
- Open Access
- 8 September 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 105, 106898
Precautions and recommendations towards possible cardiac manifestations of monkeypox vaccination
- 8 September 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 105, 106898
Open AccessPrecautions and recommendations towards possible cardiac manifestations of monkeypox vaccination
- Open Access
- 17 May 2022
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 28, 100319
Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria
- 17 May 2022
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 28, 100319
Open AccessEmerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria
- Open Access
- 21 September 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0257567
A national survey of hospital readiness during the COVID-19 pandemic in Nigeria
The COVID-19 pandemic continues to overwhelm health systems across the globe. We aimed to assess the readiness of hospitals in Nigeria to respond to the COVID-19 outbreak. Between April and October 2020, hospital representatives completed a modified World Health Organisation (WHO) COVID-19 hospital readiness checklist consisting of 13 components and 124 indicators. Readiness scores were classified as adequate (score ≥80%), moderate (score 50–79.9%) and not ready (score <50%). Among 20 (17 tertiary and three secondary) hospitals from all six geopolitical zones of Nigeria, readiness score ranged from 28.2% to 88.7% (median 68.4%), and only three (15%) hospitals had adequate readiness. There was a median of 15 isolation beds, four ICU beds and four ventilators per hospital, but over 45% of hospitals established isolation facilities and procured ventilators after the onset of COVID-19. Of the 13 readiness components, the lowest readiness scores were reported for surge capacity (61.1%), human resources (59.1%), staff welfare (50%) and availability of critical items (47.7%). Most hospitals in Nigeria were not adequately prepared to respond to the COVID-19 outbreak. Current efforts to strengthen hospital preparedness should prioritize challenges related to surge capacity, critical care for COVID-19 patients, and staff welfare and protection.
- 21 September 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0257567
Open AccessA national survey of hospital readiness during the COVID-19 pandemic in Nigeria
The COVID-19 pandemic continues to overwhelm health systems across the globe. We aimed to assess the readiness of hospitals in Nigeria to respond to the COVID-19 outbreak. Between April and October 2020, hospital representatives completed a modified World Health Organisation (WHO) COVID-19 hospital readiness checklist consisting of 13 components and 124 indicators. Readiness scores were classified as adequate (score ≥80%), moderate (score 50–79.9%) and not ready (score <50%). Among 20 (17 tertiary and three secondary) hospitals from all six geopolitical zones of Nigeria, readiness score ranged from 28.2% to 88.7% (median 68.4%), and only three (15%) hospitals had adequate readiness. There was a median of 15 isolation beds, four ICU beds and four ventilators per hospital, but over 45% of hospitals established isolation facilities and procured ventilators after the onset of COVID-19. Of the 13 readiness components, the lowest readiness scores were reported for surge capacity (61.1%), human resources (59.1%), staff welfare (50%) and availability of critical items (47.7%). Most hospitals in Nigeria were not adequately prepared to respond to the COVID-19 outbreak. Current efforts to strengthen hospital preparedness should prioritize challenges related to surge capacity, critical care for COVID-19 patients, and staff welfare and protection.